• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Lung function trajectories in mild COVID-19 with two-year follow-up

tetano

Editor, Senior Moderator
J Infect Dis


. 2024 Jan 25:jiae037.
doi: 10.1093/infdis/jiae037. Online ahead of print. Lung function trajectories in mild COVID-19 with two-year follow-up

Katrine K Iversen[SUP] 1 [/SUP], Andreas Ronit[SUP] 1 2 [/SUP], Magnus G Ahlström[SUP] 3 [/SUP], Børge G Nordestgaard[SUP] 4 5 6 [/SUP], Shoaib Afzal[SUP] 4 5 6 [/SUP], Thomas Benfield[SUP] 1 [/SUP]



Affiliations
Abstract

Objective: To characterize lung function dynamics in individuals with mild COVID-19 from pre-infection to two years post-infection.
Methods: We re-invited participants two years after infection from our matched cohort study of the Copenhagen General Population who had initially been examined 5.4 months after infection. We repeated lung tests and questionnaires. Linear mixed models were used to estimate lung volume changes in individuals with COVID-19 patients versus uninfected controls over two intervals: from pre-infection to six months post-infection and six months post-infection to two years post-infection.
Results: 52 individuals (48.6%) attended the two-year examination at median 1.9 years (IQR 1.8; 2.4) after COVID-19, all with mild infection. Individuals with COVID-19 had an adjusted excess decline in FEV1 of 13.0 mL per year (CI 23.5; 2.5), p=0.02 from prior infection to 6 months after infection compared to uninfected controls. From 6 to 24 months after infection, they had an excess decline of 7.5 mL per year (CI 25.6; 9.6), p=0.40. A similar pattern was observed for FVC. Participants had a mean increase in DLco of 3.33 (SD 7.97) between the 6- and 24-month examination.
Conclusion: Our results indicate that mild COVID-19 infection affects lung function at time of infection with limited recovery two years after infection.

Keywords: coronavirus disease 2019; forced expiratory volume in one second; forced vital capacity; respiratory symptoms; severe acute respiratory syndrome coronavirus 2; spirometry.

 
Back
Top Bottom